A Study to Evaluate Quantitative Phenotypes of Movement Disorders


About this study

The purpose of this study is to determine if adaptive rhythmic auditory stimulation (ARAS) is a safe means of improving gait; i.e., fewer falls, abrupt accelerations/decelerations in patients with movement disorders. Furthermore, we aim to provide patients with a safe environment in which they can safely navigate through an enjoyable experience (guided art tour) that provides exercise, social engagement, and exposure to art.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who have been diagnosed with movement disorder with severity of 2, 3, or 4 on the widely used Hoen & Yahr disease severity scale which has a low score of 1 indicating minimal disease severity where a score of 5 indicates being wheelchair dependent.
  • Patients must be able to ambulate either independently or with aid of a rolling walker.

Exclusion Criteria:

  • Gait impairments due to poor visual acuity.
  • Gait impairments due to musculoskeletal pathology.
  • Evidence of cerebellar dysfunction; i.e., Ataxia.
  • Evidence of lower extremity sensory loss.
  • Other miscellaneous gait impairments.
  • Allergy to silver.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Philip Tipton, M.D.

Open for enrollment

Contact information:

Audrey Strongosky C.C.R.C.


More information


Publications are currently not available